scandal

Showing 15 posts of 15 posts found.

gsk_boronia_australia

GSK to reintroduce bonuses for sales reps

May 24, 2019
Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal

British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …

johnson_and_johnson_jj

J&J announces $5bn share repurchase

December 18, 2018
Manufacturing and Production J&J, JJ, Shares, asbestos, baby powder, reuters, scandal

New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …

Further six officials fired from China FDA

August 21, 2018
Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal

A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …

li_keqiang_chinese_and_foreign_press_conference

Chinese premier slams drug maker after vaccine scandal

July 23, 2018
Sales and Marketing CCP, China, biotech, scandal, vaccines

Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …

legal

Antitrust investigation launched into Mylan and the EpiPen scandal

September 7, 2016
Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal

The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …

bill_ackman

Big investor hits back at critics as Valeant’s war of words gathers pace

May 3, 2016
Manufacturing and Production, Sales and Marketing Valeant, ackman, allegations, buffett, practices, price gouging, price rises, scandal

Valeant have hit the mainstream news again after key investor Bill Ackman mounted a robust defence of the company, ruling …

boots2

Sticking the boot in

April 18, 2016
Sales and Marketing Boots, Cost, Guardian, NHS, prescribing, scandal, unfair

A recent exposé has shone a light on the practices allegedly enforced at the nation’s largest pharmacy. So what exactly …

valeant

Valeant ends controversial litigation with R&O Pharmacy

March 10, 2016
Litigation, Philidor, Valeant, controversy, r&o pharmacy, scandal

Valeant has announced that, in conjunction with R&O Pharmacy, its has jointly requested that the Court dismiss the litigation between …

GSK image

GSK investigator freed from Chinese prison

June 10, 2015
Medical Communications, Sales and Marketing China, GSK, GlaxoSmithKline, brett wells, bribery, scandal

British private investigator Peter Humphrey who worked for GlaxoSmithKline has been released from a Chinese jail following his conviction last …

gsk image

Another major drop in sales for GSK

July 23, 2014
Sales and Marketing China, GSK, Q2, Witty, bribery, sales, scandal, sex

GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …

robert_francis

Francis report author becomes Patients Association president

November 28, 2013
Sales and Marketing Mid Staffs, NHS, robert francis, scandal

The author of a damning report into failings at the Staffordshire hospital has become the new president of the Patients …

Mike Farrar image

NHS Confederation chief executive quits to be a consultant

September 11, 2013
Medical Communications, Sales and Marketing Mike Farrar, NHS, scandal

Mike Farrar is to stand down as chief executive of the NHS Confederation at the end of the month in …

GSK image

GSK admits: Execs ‘breached Chinese law’

July 22, 2013
Medical Communications, Sales and Marketing China, GSK, bribes, scandal

A senior GlaxoSmithKline executive has admitted that some of the firm’s staff have broken the law in China as a …

Latest content